LSI Stock Overview
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
CK Life Sciences Int'l., (Holdings) Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.035 |
| 52 Week High | HK$0.089 |
| 52 Week Low | HK$0.032 |
| Beta | 0.22 |
| 1 Month Change | -9.09% |
| 3 Month Change | -44.00% |
| 1 Year Change | -59.06% |
| 3 Year Change | -55.97% |
| 5 Year Change | -28.57% |
| Change since IPO | -44.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| LSI | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 0% | -3.1% | 1.8% |
| 1Y | -59.1% | -22.4% | 2.2% |
Return vs Industry: LSI underperformed the German Biotechs industry which returned -22.4% over the past year.
Return vs Market: LSI underperformed the German Market which returned 2.2% over the past year.
Price Volatility
| LSI volatility | |
|---|---|
| LSI Average Weekly Movement | 10.6% |
| Biotechs Industry Average Movement | 5.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: LSI's share price has been volatile over the past 3 months.
Volatility Over Time: LSI's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 1,932 | Alan Abel Yu | www.ck-lifesciences.com |
CK Life Sciences Int'l., (Holdings) Inc., an investment holding company, researches, develops, manufactures, commercializes, markets, and sells health and agriculture-related products in the Asia Pacific and North America. It manufactures and markets plant protection products and soluble fertilizers; manufactures, blends, distributes, and sells fertilizers, pesticides, and related agricultural products; manufactures and distributes horticultural products for the home gardening market; and produces non-sterile prescription and over-the-counter medicines. The company is also involved in the contract manufacturing of complementary healthcare medicines, pharmaceutical products, and cosmetics; licensing of registration activities and the importation of finished agricultural goods; holding of land and buildings; financing activities; investment in financial instruments and vineyards; trading of biotechnology products and nutritional supplements; and manufacturing, wholesaling, retailing, and distribution of nutraceutical products.
CK Life Sciences Int'l., (Holdings) Inc. Fundamentals Summary
| LSI fundamental statistics | |
|---|---|
| Market cap | €395.64m |
| Earnings (TTM) | €2.06m |
| Revenue (TTM) | €635.10m |
192.2x
P/E Ratio0.6x
P/S RatioIs LSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LSI income statement (TTM) | |
|---|---|
| Revenue | HK$5.32b |
| Cost of Revenue | HK$3.69b |
| Gross Profit | HK$1.64b |
| Other Expenses | HK$1.62b |
| Earnings | HK$17.25m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0018 |
| Gross Margin | 30.76% |
| Net Profit Margin | 0.32% |
| Debt/Equity Ratio | 129.4% |
How did LSI perform over the long term?
See historical performance and comparison